Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Natera
company
About
Natera specializes in cell-free DNA testing to elevate the science and utility of prenatal testing.
- San Carlos,California,United States
- 1001 - 5000
- http://www.natera.com
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $6M
- Industries
- Biotechnology,Genetics,Health Diagnostics,Medical
- Founded date
- Jan 1, 2004
- Number Of Employee
- 1001 - 5000
- Operating Status
- Active
- Stock Symbol
- fra:45E
- Legal Name
- Natera Inc.
- Also Known As
- Gene Security Network
Natera specializes in cell-free DNA testing is driven by a passion for elevating the science and utility of prenatal testing. The advent of the Information Age has created a paradigm shift in the fields of computing and informatics. Surprisingly, medical diagnostics have been slow to integrate these advances into genetic testing.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
12
$809.15M
Natera has raised a total of
$809.15M
in funding over 2 rounds. Their latest funding was raised on
Nov 15, 2022 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 15, 2022 | Post-IPO Equity | $400.05M | — | — | — | Detail |
| Mar 16, 2022 | Post-IPO Equity | $5M | 2 |
Matthew Rabinowitz
Roelof Botha
|
— | Detail |
| Apr 13, 2020 | Post-IPO Equity | $250M | — | — | — | Detail |
| Jul 10, 2015 | IPO | — | — | — | — | Detail |
| Apr 6, 2015 | Series F | $55.50M | 7 |
Sofinnova Investments
|
— | Detail |
Investments
Number of Investments
Number of Lead Investments
4
0
Natera has made 4 investments. Their most recent investment was on
Jun 21, 2022, when Myome raised $23M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jun 21, 2022
Myome
|
Series B | $23M | Biotechnology | — |
|
Jun 30, 2021
Kriptomat
|
Seed | €2.20M | Blockchain | — |
|
Dec 7, 2016
doctoranytime
|
Angel | €1M | Beauty | — |
|
Aug 2, 2015
Blueground
|
Seed | $189.64K | Hospitality | — |
Investors
Number of Lead Investors
Number of Investors
7
15
Natera is funded by 15 investors.
Matthew Rabinowitz
and Roelof Botha
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Matthew Rabinowitz
|
Yes | Post-IPO Equity |
|
Roelof Botha
|
Yes | Post-IPO Equity |
|
Sofinnova Investments
|
Yes | Series F |
|
|
Yes | Series E |
Sequoia Capital
|
— | Series F |
Franklin Templeton Investments
|
— | Series F |
HealthCor Partners
|
— | Series F |
Jennison Associates
|
— | Series F |
OrbiMed
|
— | Series F |
RA Capital Management
|
— | Series F |
Employee Profiles
Number of Employee Profiles
23
Natera has 23 current employee profiles, including
Executive Jonathan Sheena
Executive
Executive
Executive
Executive
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
